Midodrine administration during critical illness: fixed-dose or titrate to response?
- PMID: 33237345
- PMCID: PMC8613827
- DOI: 10.1007/s00134-020-06321-x
Midodrine administration during critical illness: fixed-dose or titrate to response?
Conflict of interest statement
Declarations
Conflicts of Interest/ Competing Interests
The authors declare no competing interests.
Comment in
-
High-dose midodrine is not effective for treatment of persistent hypotension in the intensive care unit.Intensive Care Med. 2021 Feb;47(2):252-253. doi: 10.1007/s00134-020-06333-7. Epub 2021 Jan 8. Intensive Care Med. 2021. PMID: 33416917 No abstract available.
Comment on
-
Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.Intensive Care Med. 2020 Oct;46(10):1884-1893. doi: 10.1007/s00134-020-06216-x. Epub 2020 Sep 3. Intensive Care Med. 2020. PMID: 32885276 Free PMC article. Clinical Trial.
References
-
- Santer P, Anstey MH, Patrocínio MD, Wibrow B, Teja B, Shay D, Shaefi S, Parsons CS, Houle TT, Eikermann M, MIDAS Study Group (2020) Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial. Intensive Care Med September 3. doi: 10.1007/s00134-020-06216-x. Online ahead of print - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical